- NCT00236873
- Primary Citation
- Data Specification Not Available
You are not logged in.
Please login to continue selecting trials.
Trial Information
Generic NameTopiramateProduct NameTOPAMAX®Therapeutic AreaNervous System DiseasesEnrollment47% Female14.9%% White100%
Product ClassAnticonvulsantsSponsor Protocol NumberY1 (CC2604-C-101)Data PartnerJohnson & JohnsonCondition StudiedEpilepsyMean/Median Age (Years)34
Supporting Documentation
- Collected Datasets Available
- Protocol with Amendments Available